Company Filing History:
Years Active: 1998-1999
Title: Ruediger Marquardt: Innovator in Nucleotide Synthesis
Introduction
Ruediger Marquardt is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of biochemistry, particularly in the synthesis and purification of nucleotide-activated sugars. With a total of 2 patents, Marquardt's work has implications for various applications in biotechnology and pharmaceuticals.
Latest Patents
Marquardt's latest patents include a process for the synthesis of nucleotide-6-deoxy-D-xylo-4-hexuloses. This invention relates to enzymatic synthesis starting from a nucleoside monophosphate (NMP). The process involves the simultaneous incubation of specific substances in a buffer solution. Another significant patent is for an improved process for isolating and purifying sugar nucleotides, particularly cytidine monophosphate-activated N-acetylneuraminic acid (CMP-Nana). This method enhances the purification of sugar nucleotides from biological sources using an improved column-chromatographic technique with silica gel as the stationary phase.
Career Highlights
Ruediger Marquardt is associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical and chemical sectors. His work at Hoechst has allowed him to focus on innovative processes that advance the field of nucleotide chemistry.
Collaborations
Marquardt has collaborated with notable colleagues such as Andreas Seiffert-Stoeriko and Brigitte Hoersch. These collaborations have contributed to the development of his patents and the advancement of research in his field.
Conclusion
Ruediger Marquardt's contributions to the synthesis and purification of nucleotide-activated sugars highlight his role as an innovator in biochemistry. His patents reflect a commitment to advancing scientific knowledge and practical applications in the industry.